首页|期刊导航|Hepatobiliary & Pancreatic Diseases International|Exosomal hnRNPA2B1 suppresses irinotecan-induced ferroptosis in pancreatic cancer

Exosomal hnRNPA2B1 suppresses irinotecan-induced ferroptosis in pancreatic cancerOA

中文摘要

Background:Irinotecan is a commonly used chemotherapeutic drug for pancreatic cancer(PC),but its specific mechanism of inducing cell death is yet to be elucidated.Exosomes are key mediators of in-tercellular communication and are involved in tumorigenesis.This study aimed to investigate whether irinotecan-induced ferroptosis can inhibit PC progression,and to explore the mechanism of exosomes derived from PC cells reverse irinotecan-induced ferroptosis.Methods:Exosomes were isolated from cells via polymer precipitation method.CCK8 assay and colony formation assay were used to test the proliferation of PC cells.Wound-healing assay and Transwell mi-gration assay were used to test the migration of PC cells.Ferroptosis in cells was detected by analysis of malondialdehyde,glutathione,Fe2+and reactive oxygen species concentrations.Transmission electron microscopy was used to observe the morphology of intracellular mitochondria.Related proteins were de-tected by Western blot.Results:Irinotecan could inhibit the proliferation of PC cells,decrease the expression of the ferroptosis-negative regulators glutathione peroxidase 4 and cystine transporter solute carrier family 7 member 11,and increase the intracellular concentrations of Fe2+and ferroptosis metabolites.However,exosomes de-rived from PC cells inhibit irinotecan-induced ferroptosis and diminish the anti-tumor effect,whereas this effect was significantly reduced following the knockdown of hnRNPA2B1.Conclusions:These findings indicated that exosomal hnRNPA2B1 could inhibit irinotecan-induced ferrop-tosis of PC,which strongly regulated the progression and drug resistance of PC.

Xu-Lin Zhou;Wei Liu;Xiao-Chun Sun;Tian Li;Yong-Min Yan;Da-Wei Cui;Xiang Wang;Min Xu

Department of Gastroenterology,Affiliated Hospital of Jiangsu University,Zhenjiang 212001,ChinaJiangsu University School of Medicine,Jiangsu University,Zhenjiang 212001,ChinaJiangsu University School of Medicine,Jiangsu University,Zhenjiang 212001,ChinaTianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair,Institute of Integrative Medicine of Acute AbdominalDiseases,Tianjin Nankai Hospital,Tianjin Medical University,Tianjin 300100,ChinaDepartment of Laboratory Medicine,Wujin Hospital Affiliated with Jiangsu University,Changzhou 213000,ChinaDepartment of Blood Transfusion,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,ChinaZhejiang Key Laboratory of Integrated Oncology and intelligent Medicine,Affiliated Hangzhou First People’s Hospital,Westlake University School ofMedicine,Hangzhou 310000,ChinaDepartment of Gastroenterology,Affiliated Hospital of Jiangsu University,Zhenjiang 212001,China

医药卫生

Pancreatic cancerExosomesIrinotecanFerroptosis hnRNPA2B1

《Hepatobiliary & Pancreatic Diseases International》 2026 (4)

P.432-445,14

approved by the Medical Ethics Committee of Jiangsu University(UJS-IACUC-AP-2020041402).

10.1016/j.hbpd.2026.04.002

评论